相关实验视频

Updated: Jan 10, 2026

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Quantification of the Immunosuppressant Tacrolimus on Dried Blood Spots Using LC-MS/MS

Published on: November 8, 2015

评估巴西利克西马布诱导在同时肝移植中的作用:多中心倾向-得分匹配分析

Avery Koi¹, Trine Engebretsen², Alfred S Lea³

¹John Sealy School of Medicine, The University of Texas Medical Branch, Galveston, TX 77555, USA.

Antibodies (Basel, Switzerland)

|November 24, 2025

概括

没有诱导巴西西西马布的同时进行肝移植的患者有类似的排斥率,但病毒感染更多. 这表明,类固醇节约方案可能会增加这些复杂受体的感染风险.

科学领域:

移植免疫学移植免疫学
器官移植的结果.
免疫抑制策略免疫抑制策略

背景情况:

同时肝移植 (SLK) 接受者通常被认为具有较低的免疫风险,导致一些中心使用仅类固醇诱导.
然而,在一些机构中,SLK协议中的巴西西马布诱导的使用仍然存在.
这项研究调查了巴西利克西马布诱导对SLK移植接受者的移植和感染结果的影响.

研究的目的:

为了比较SLK接受者之间的移植和感染结果,他们接受了巴西西马布诱导和那些没有接受的人.
评估SLK移植协议中省略巴西利克西马布的安全性和有效性.

主要方法:

使用TriNetX数据库进行了一项回顾性,倾向性得分匹配的研究.
根据巴西西马布诱导的存在 (Bas) 或缺乏 (No Bas) 来比较SLK接受者.
评估的结果包括移植拒绝,移植失败,再移植,感染 (CMV,EBV) 和移植后3,6和12个月的死亡率.

主要成果:

在倾向得分匹配后,每个队列分析了292名患者.
和肝移植的排斥率在BAS和无BAS组之间是相似的.
没有BAS队伍的细胞巨化病毒 (CMV) 和爱斯坦-巴尔病毒 (EBV) 感染率更高,肝脏活检也更多.
肝脏初级非功能在巴斯队列中更频繁,而移植失败,再移植和死亡率相似.

结论:

没有巴西西马布诱导的SLK接受者表现出与接受它的人相似的排斥结果.
省略巴西力西马布与病毒感染 (CMV,EBV) 的发病率增加以及肝脏活检的数量增加有关.
这些发现表明,虽然巴西利克西马布可能对防止SLK接受者的排斥无关紧要,但其缺乏可能与病毒感染的增加有关,可能是由于较大的类固醇暴露.

关键词:

在TriNetX数据库中,我们可以使用TriNetX数据库.这就是Basiliximab.肝脏和脏的联合移植.诱导性免疫抑制是一种诱导性免疫抑制.一个回顾性病例控制研究.同时进行肝移植.

更多相关视频

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

Mouse Kidney Transplantation: Models of Allograft Rejection

Mouse Kidney Transplantation: Models of Allograft Rejection

Published on: October 11, 2014

相关概念视频

Kidney Transplant I: Introduction

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

Kidney Transplant II: Surgical Procedure

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...